Epidemiological studies of postmenopausal hormone replacement therapy show a reduction in the risk of developing colon cancer, and animal studies using 17 -oestradiol (E 2 ) demonstrate a decreased incidence of chemically-induced colon cancer. Using the colon cancer cell line, COLO205, we found that E 2 induced a dose-dependent increase in DNA fragmentation and nuclear condensation, significant effects being seen at 10 12 mol/l. BSA-conjugated E 2 , which cannot enter cells, was ineffective at inducing apoptosis in COLO205 cells, indicating that E 2 was not acting through a cell-membrane receptor. E 2 did not induce the morphological changes characteristic of differentiation.
Introduction
The epidemiological finding that the risk of colorectal cancer is reduced among postmenopausal hormone users was unexpected, but has been consistently confirmed. Thus, in their meta-analysis Grodstein et al. (1999) found a one-fifth reduction in the frequency of cancer of the colon and rectum in women who had ever used postmenopausal hormones (predominantly conjugated oestrogen), compared with never users. There are also animal models showing that male rats have a higher risk of developing colon cancer compared with their female counterparts when exposed to dimethylhydrazine, an experimental carcinogen. That effects are likely to be direct is indicated by evidence that 17 -oestradiol (E 2 ) treatment can reduce significantly the frequency of dimethylhydrazine-induced large intestinal tumours in rats (Smirnoff et al. 1999) .
The effects of E 2 are mediated by two specific, high affinity oestrogen receptors, ER and ER , ligandactivated or ligand-independent transcription factors which modulate gene expression by interaction with promoter response elements or other transcription factors , Muramatsu & Inoue 2000 . Although both receptors have been identified in breast, bone, cardiovascular tissue, the urogenital tract and the central nervous system, ER is the form that predominates in the gastrointestinal tract (Gustafsson 1999 , CampbellThompson et al. 2001 . Foley et al. (2000) showed that malignant transformation in the colon is associated with a marked diminution of ER protein expression.
Multiple variant forms of ER and ER mRNAs have been identified (Murphy et al. 1997 , Lu et al. 1998 , Yang et al. 2000 . These show differential expression in human tissues suggesting different functions and may explain the heterogeneous response of tissues to E 2 . The ER isoforms, which differ from each other in the C-terminal sequences, can form DNA-binding homodimers and heterodimers with each other and with ER (Moore et al. 1998) . A variant of ER which lacks exon 5 has been shown to have dominant negative activity on both ER and ER , illustrating the potential of these multiple isoforms to regulate tissue responsiveness to E 2 (Moore et al. 1998 , Ogawa et al. 1998 . In breast tumours, increases in the ratios of ER 2 and ER 5 to ER 1 mRNA expression have been observed (Leygue et al. 1999) . In colon cancer cells functional ER , measured by E 2 induction of progesterone binding and by E 2 effects on cell viability and growth, have been found, but no ER was detected in HCT116, HCT8, DLD-1, and LoVo colon cancer cell lines (Fiorelli et al. 1999) . CampbellThompson et al. (2001) also found little or no ER , but ER 1, -2 and -5 isoforms were present in HT-29, CACO-2, T84 and SW1116 colon cancer cell lines.
The mechanisms by which E 2 might protect against colon cancer are unclear. Contributory roles for ER in the regulation of cell differentiation in osteoblast cells (Arts et al. 1997) and in the induction of apoptosis in neuronal cells (Nilsen et al. 2000) have been documented, where it is suggested that E 2 can function as a survival agent or an inducer of apoptosis depending on the ER subtype present in cells. Apoptotic cell death in epithelial lineages generally occurs after a terminal differentiation event (Counis et al. 1989 , Wyllie 1992 . Thus, terminal differentiation is involved in butyrate-and vitamin D 3 -induced apoptosis in colon cancer cell lines. The mechanism of action of E 2 is further complicated by the findings that non-genomic effects occur in the vasculature, breast, bone, uterus and neuronal tissues. In these tissues, E 2 can induce extremely rapid increases in the levels of intracellular second messengers, including Ca 2+ and cAMP, as well as activation of MAP kinase and phospholipase C (Gu & Moss 1996 , Migliaccio et al. 1996 , Picotto et al. 1996 , Chieffi et al. 2000 .
In seeking to determine whether, and if so how, E 2 protects against colon cancer, we have assessed the effects of E 2 on apoptosis and differentiation in a colon cancer cell line (COLO205), at concentrations to be expected during hormone replacement therapy (HRT) (Belchetz 1994) . We found that this cell line expresses ER only and therefore results with this cell line have been compared with cells expressing ER . We further investigated ER isoform expression in epithelium from normal and cancerous human colon tissues.
Materials and Methods

Materials
Five human colon cancer cell lines, COLO205, LoVo, SW620, CACO-2 and HT-29, were obtained from the European Animal Cell Culture Collection (EACC, Porton Down, Wilts, UK). COLO205 cells were derived from the ascites fluid of a 70-year-old Caucasian male with colorectal cancer. LoVo cells were established from the metastatic nodule resected from a 56-year-old colon adenocarcinoma patient, SW620 cells were established from the lymph node of a 51-year-old Caucasian male, CACO-2 cells were derived from primary colon tumour (adenocarcinoma) of a Caucasian male and HT-29 cells were established from the primary tumour of a 44-year-old Caucasian. In addition, a human adenoma cell line, AASB, was generously provided by Professor C Paraskeva (University of Bristol, UK) and two human breast cancer cell lines, MCF-7 and MDAMB231, were generously provided by the Department of Surgery, University of Birmingham, UK.
COLO205 cells were examined for apoptotic responses by DNA fragmentation and by acridine orange/propidium iodide staining. These and HT-29, CACO-2, LoVo, SW620 and AASB cell lines were also examined by RT-PCR and Western blotting for ER isoforms, with MCF-7 and MDAMB231 as controls. Results were compared with human colon cancer samples and adjacent normal mucosa. E 2 (Sigma Chemicals Corporation) was dissolved in ethanol at a stock concentration of 10 2 mol/l. Cyclodextrin-encapsulated E 2 (water-soluble E 2 from Sigma Chemicals Corporation) was dissolved in Milli-Q distilled water (Millipore Ltd, Watford, UK) at a stock concentration of 10 2 mol/l, and 2-hydroxypropyl--cyclodextrin (Sigma Chemicals Corporation) was used as control for this agent. The -oestradiol 17-hemisuccinate:BSA conjugate (BSA-E 2 , Sigma Chemical Corporation) was dissolved in Milli-Q distilled water to give a stock concentration equivalent to 10 2 mol/l E 2 , and dialysed for 24 h against 0·9% NaCl in Milli-Q distilled water to remove unconjugated E 2 . TRIzol (GIBCO BRL) was purchased from Invitrogen Ltd, UK and Ready-To-Go RT-PCR beads were from Amersham Pharmacia Biotech Inc. (NY, USA).
Cell culture and treatment
All cell lines were maintained in phenol red-free RPMI 1640 medium (Sigma Chemical Corporation) augmented with 10% foetal bovine calf serum (FCS, First Link Ltd, West Midlands, UK), 100 U/ml penicillin G and 100 µg/ ml streptomycin sulphate (Sigma Chemical Corporation) in a humid atmosphere at 37 C, with 5% CO 2 . Cells were passaged twice a week and plated at a density of 5 10 4 cells per cm 2 and cultured for 3 days in 10% charcoal-stripped FCS (CSFCS), followed by treatment with E 2 , or BSA-conjugated E 2 , for 24-48 h in serum-free medium in the presence of antibiotics. Charcoal-stripped foetal calf serum was prepared by mixing 50 ml FCS with 5 g activated charcoal (Sigma Chemical Corporation) overnight at 4 C. Following centrifugation to remove the charcoal, a further 5 g charcoal were added to the supernatant and incubated for 30 min at 37 C and centrifuged. This was repeated one more time.
Human colon cancer and paired normal tissue
Malignant and paired normal tissues (more than 10 cm away from the tumour) were obtained from patients at the time of surgery in accordance with the guidelines of the local ethical committee, and were immediately frozen in liquid nitrogen. Total RNA and protein were extracted from frozen tissues using TRIzol reagent according to the manufacturer's recommendations.
DNA fragmentation
The apoptotic, floating fraction of COLO205 cells was collected by centrifugation and dissolved in DNA sample buffer (50 mmol/l Tris-HCl, 0·5% sodium dodecylsulphate (SDS), 10 mmol/l EDTA, pH 8·0). Incubation with RNase A (100 µg/ml) at 50 C for 1 h was followed by proteinase K (1 µg/ml) digestion at 50 C for 1 h and incubation at 70 C for 10 min. DNA was resolved by electrophoresis on a 2% agarose gel stained with ethidium bromide, and visualised by UV illumination.
Acridine orange/propidium iodide staining
Both floating and attached COLO205 cells were collected and suspended in Hank's Balanced Salt Solution (HBSS) with acridine orange (5 µg/ml) and propidium iodide (5 µg/ml) (Gregory et al. 1991) . A drop of the stained cell suspension was placed on a microscope slide and immediately viewed by fluorescence microscopy. Early apoptotic cells had bright nuclei with dense green areas, while late apoptotic cells had dense orange nuclei. Necrotic fragments, which stained red but had lost cellular structure due to cell membrane lysis, were ignored. Each treatment was repeated in triplicate and the cell counts were performed on a random field at 100 magnification for each sample. The entire field was counted and on no occasion was this less than 100 cells. The data were corrected for percentage of apoptotic cells.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was quantified by spectrometry ( 260 nm). ER was amplified using a pair of appropriate oligonucleotide primers as follows: ER forward primer 5 -CCG CTC ATG ATC AAA CGC TCT AAG-3 (sequence position 1243-1266, Genbank accession no. NM000125), reverse primer 5 -GCC CTC TAC ACA TTT TCC CTG GTT-3 (1620-1597, NM000125). The , indicates viable cells. , indicates early apoptotic cells and , shows late apoptotic cells. (B) Dose-response effect of E 2 on the apoptosis in COLO205 cells. COLO205 cells were incubated as described for DNA fragmentation analysis. Floating and attached cells were pooled and acridine orange/propidium iodide staining was performed as described in Materials and Methods. The percentage of apoptotic cells (means S.E.M.) was plotted against concentrations of E 2 (n=3). *P<0·05, **P<0·01 compared with control (Con).
expression of human ER isoforms was also determined. The forward primer for the ER 1-ER 5 isoforms was the same because they share the common sequence (5 -AGT ATG TAC CCT CTG GTC ACA GCG-3 , 1666-1643, AF051427), while the reverse primers specific for the isoforms 1 to 5 were as follows: ER 1: 5 -CCA AAT GAG GGA CCA CAC AGC AG-3 (1560-1638, X99101); ER 2: 5 -GGA TTA CAA TGA TCC CAG AGG GAA ATT G-3 (1987 -1960 ; ER 3: 5 -GCA GTC AAG GTG TCG ACA AAG GCT GC-3 (2094-2069, AF060555); ER 4: 5 -GGA TTA CAA TGA TCC CAG AGG GAA ATT G-3 (1987 -1960 ; ER 5: 5 -CTT TAG GCC ACC GAG TTG ATT AGA G-3 (372-348, AF061054). In addition, the forward primer 5 -GTT GGC CGA CAA GGA GTT GG-3 (27-46, AF074598) and reverse primer 5 -ACG GCG TTC AGC AAG TGA GC-3 (291-272, AF074598) were used to amplify the transcript of ER 6. ER 6 was identified and submitted to Genbank by A W Brandenberger in 1998 (Genbank no. AF074598). RT-PCR was performed by standard methods. Briefly, RT-PCR beads were resuspended in 44 µl diethyl pyrocarbonate (DEPC)-treated dH 2 O, and 1 µg total RNA template and 2·5 µg random hexamer primer were added. Incubation was carried out at 42 C for 20 min, followed by 95 C for 5 min. Indicated primer pairs (10 pmol) were added to give a final total volume of 50 µl. PCR was performed for 35 cycles at 94 C for 1 min, 60 C for 1 min, and 72 C for 90 s. A single cycle of 72 C for 7 min completed the reaction. Products were resolved on a 2% agarose gel stained with ethidium bromide, and visualised by UV illumination. For negative controls, total RNA was amplified with heat-inactivated RT-PCR beads to confirm absence of contamination from genomic DNA, and dH 2 O was used as a template to determine contamination from the laboratory environment in each RT-PCR reaction.
Western immunoblotting
Floating and adherent COLO205 cells were pooled and washed with HBSS twice, followed by dissolution in lysis buffer (2% SDS, 62·5 mmol/l Tris-HCl, pH 6·8). Proteins were also extracted from frozen tissues using TRIzol reagent according to the manufacturer's recommendations and dissolved in lysis buffer. Protein concentration was assayed using the method described by Bio-Rad (DC Protein Assay, Bio-Rad Laboratories, Hercules, CA, USA) with bovine serum albumin as standard. One hundred micrograms protein were separated on a 10% SDSpolyacrylamide gel with a 5% stack under reducing conditions. The separated proteins were transferred to a polyvinylidene difluoride membrane (Amersham Pharmacia Biotech Inc., USA) for 3 h at 450 mA. Nonspecific binding was blocked by incubating the membrane in 10% low-fat milk in Tris-buffered saline-Tween 20 (TBS-T, 10 mmol/l Tris-HCl, pH 7·5, 100 mmol/l NaCl, 0·1% Tween 20) for 2 h at room temperature. The blot was incubated with 1:1000 dilution of anti-ER (Santa Cruz, Autogen Bioclear UK Ltd) or anti-ER (DAKO, Cambridgeshire, UK) antibody in TBS-T with 0·25% BSA overnight at 4 C. After exposure to primary antibody, the blot was washed in TBS-T and incubated with horseradish peroxidase-conjugated anti-rabbit immunoglobulin (1: 50 000 dilution in TBS-T with 0·25% BSA, Santa Cruz) or anti-mouse (1:20 000 dilution, Binding Site, Birmingham, UK) for 1 h at room temperature and washed again. LumiGLO Chemiluminescent Substrate (Kirkegaard & Perry Laboratories, MD, USA) and X-ray films (Kodak, UK) were used for detection of immunoreactive species. The monoclonal antibody to ER was developed using a full-length recombinant ER as an antigen for immunisation of Balb-c mice and has been tested for cross reaction to ER protein in an ELISA. No cross-reactivity with full length recombinant ER was observed (Anwar et al. 2001) . The antibody will recognise (1) and (2)) and 100 g ( (3) and (4) ER 1 and most probably other ER isoforms. ER antibody is commercially available from Santa Cruz and shows no cross reactivity with ER .
Statistical analysis
Statistical analyses were performed using one-way analysis of variance (ANOVA), and Dunnett's multiple comparison tests. A P value <0·05 was considered significant.
Results
DNA fragmentation
E 2 was found to induce apoptosis dose-dependently in COLO205 cells at concentrations of 10 10 -10 7 mol/l (Fig. 1) . Results shown are representative of individual experiments repeated in triplicate. Apoptosis measured by this assay was not found in CACO-2, LoVo and SW620 cells with E 2 treatment (data not shown).
Acridine orange/propidium iodide staining
Cell counting results confirmed the findings of DNA fragmentation with increasing E 2 . Figure 2A shows examples of viable, early and late apoptotic cells; early apoptotic cells had bright nuclei with dense green areas, while late apoptotic cells had dense orange nuclei. Figure 2B demonstrates that treatment for 48 h with E 2 induced apoptosis dose-dependently, with a maximum at 10 10 mol/l (mean percentage apoptosis=38·5, P<0·01), but with clearly demonstrable effects at 10 12 mol/l, and evidence of diminishing responsiveness at 10 8 mol/l.
RT-PCR and Western immunoblotting of ER isoforms
The transcript for ER mRNA was not detected in COLO205 cells or HT-29 cells, but was detectable in CACO-2, LoVo, and SW620 cells (Fig. 3A) . ER was also present in MCF-7 cells (a human breast cancer cell line serving as a positive control), but absent in MDAMB231, a breast cancer cell line previously found to be ER negative (Horwitz et al. 1978) . Figure 3B shows that transcripts for ER 1, -2 -5 and -6, with PCR products of 477, 345, 372 and 265 bp fragments respectively, were detected in COLO205 cells, no other ER isoforms being found. ER 3 and ER 4 were not detected in any of the colon cancer cell lines while the remaining isoforms were variably expressed. HT-29 cells did not express ER 1 and ER 2. MCF-7 cells expressed ER 1, -5 and -6, and transcripts for ER 1, -2, -3 and -6 were detected in the MDAMB231 cell line. All cell lines examined expressed ER 6. Western immunoblotting results of expression of ERs further confirmed that ER was not detected in Figure 6 Western immunoblotting analysis of ER expression in colon cancer and paired normal tissue samples. ER is expressed as a double band of 52-58 kDa detected when using monoclonal anti-ER antibody. C, cancerous tissues; and N, corresponding normal tissues. COLO205 or MDAMB231 cells but was present in MCF-7 and CACO-2 cells (data not shown) as a 65 kDa protein. ER was expressed in both MCF-7 cells and COLO205 cells as a 56 kDa band (Fig. 4) .
The expression profiles of ER mRNAs in human colon cancer and paired normal tissues are shown in Fig. 5A and B. ER , ER 2, -5 and -6 were found in both the cancer and the normal tissues but expression did not vary consistently between them. Neither ER 3 nor ER 4 was identified. ER 1 expression was variable, but no obvious difference was found in the frequency of ER 1 expression between the human colon cancer and paired normal tissues. We examined ER expression further by Western immunoblotting of paired normal and cancer tissue from sites throughout the colon. Specific staining of 65 kDa ER was very low in all tissues (data not shown), as previously reported by Foley et al. (2000) . ER was detected as a dimer of 52 and 58 kDa as shown in Fig. 6 . In two of the cancer samples these bands were absent and in two others they were markedly reduced. One sample showed no change between normal and cancer tissues.
Effect of BSA-conjugated E 2 on apoptosis in COLO205 cells
To determine whether E 2 -induced apoptosis is mediated by membrane receptors, we treated COLO205 cells for 48 h in serum-free medium with BSA-E 2 with concentrations equivalent to 10 11 -10 7 mol/l E 2 . DNA fragmentation analysis was performed. As shown in Fig. 7 , BSA-conjugated E 2 had no effect on apoptosis. 
Effect of E 2 on cellular differentiation
The effect of E 2 on differentiation was initially assessed by alkaline phosphatase (ALP) and dipeptidyl-aminopeptidase IV (DPP IV) assays. We compared effects with those of butyrate which is known to be a differentiation inducer in some colon cancer cell lines, e.g. CACO-2 and HT-29, but there are no data of its effects in COLO205 cells. We also used herbimycin A, a tyrosine kinase inhibitor, which has been demonstrated to induce differentiation in COLO205 cells (Mancini et al. 1997) assayed by a morphological change. Neither herbimycin A nor butyrate induced changes in the activity of ALP and DPP IV in COLO205 cells. Morphological changes characteristic of differentiation were therefore used to identify the effects of E 2 on differentiation. In Fig. 8A and B, control cells appeared as isolated, small round cells with a high nucleusto-cytoplasm ratio. Following herbimycin A treatment (300 ng per ml) for 48 h, cells became larger, forming cellular aggregates, and appeared organised in epithelioid colonies (Fig. 8C ). E 2 -treated cells did not show these morphological changes (Fig. 8D ).
Discussion
We have found that E 2 consistently induced apoptosis in COLO205 cells at concentrations equivalent to those attained in women receiving HRT for post-menopausal symptoms. Effects were demonstrable by DNA fragmentation and propidium iodide staining although apoptosis was detectable at lower concentrations of E 2 (10 12 mol/l) by the propidium iodide technique than by DNA fragmentation (10 10 mol/l). This is probably due to the ability of propidium iodide to detect early and late apoptotic cells, while the DNA fragmentation technique is an indicator of late apoptosis. The lack of effect of BSA-conjugated E 2 indicates that a membrane receptor is unlikely to be involved. Nuclear ERs are well described in the large bowel (Singh et al. 1993) . We found that ER was the prevalent subtype of ER in colon cancer cell lines, which is consistent with the results shown by other groups (Arai et al. 2000 , Foley et al. 2000 . Since ER 1, -2, -5 and -6 were the only transcripts identified in COLO205 cells and no ER was seen, it follows that if nuclear ERs are responsible for apoptosis induction, then at least one of the four may be critically necessary. We did not find E 2 -induced apoptosis in CACO-2, LoVo, and SW620 cells in which both ER and ER were detectable, further suggesting ER and ER may function in opposite ways in these cells. Paech et al. (1997) showed that ER :E 2 activates whereas ER :E 2 inhibits transcription. ER is postulated to act as a survival factor, while ER mediates the induction of apoptosis (Nilsson & Gustafsson 2000) . The antiproliferative property of ER is also demonstrated in ER knockout mice, in which loss of ER function in the immature uterus causes increased expression of Ki-67, a marker of cell proliferation, and induction of insulin-like growth factor-I and vascular endothelial growth factor (Weihua et al. 2000) . Furthermore, in vitro studies have shown that ER and ER signal in opposite ways from the AP-1 site when complexed with E 2 (Paech et al. 1997) .
Examination of the expression of ERs in human colon cancer and paired normal tissues showed similar results to those of Foley et al. (2000) , who found low levels of expression of ER and selective loss of ER in malignant human colon. We found ER was expressed in both cancerous and normal human colon tissues using RT-PCR but whether this is derived from colonocytes or other contaminating cell types is impossible to resolve with RT-PCR. With Western immunoblotting, very weak signals of ER protein (65 kDa) were detected. A double band of 52 and 58 kDa was detected when using monoclonal anti-ER antibody. These bands were differentially expressed in colon cancer and normal tissues with complete loss in two, a marked reduction in two and no change in one of the colon cancer specimens.
We conclude that a likely mechanism underlying protection by HRT against colorectal cancer is by E 2 -induced apoptosis, probably mediated through nuclear ER receptors, particularly ER 1, ER 2, ER 5 and/or ER 6.
